Schrodinger [SDGR] vs Teladoc Health [TDOC] Detailed Stock Comparison
Schrodinger
NASDAQ
Loading...
Teladoc Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Schrodinger wins in 5 metrics, Teladoc Health wins in 13 metrics, with 0 ties. Teladoc Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Schrodinger | Teladoc Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.39 | -1.50 | Teladoc Health |
| Price-to-Book Ratio | 4.42 | 1.12 | Teladoc Health |
| Debt-to-Equity Ratio | 33.38 | 72.78 | Schrodinger |
| PEG Ratio | -2.19 | 0.02 | Schrodinger |
| EV/EBITDA | -6.33 | 103.14 | Schrodinger |
| Profit Margin (TTM) | -76.22% | -8.16% | Teladoc Health |
| Operating Margin (TTM) | -96.61% | -7.29% | Teladoc Health |
| Return on Equity | -44.40% | -14.18% | Teladoc Health |
| Return on Assets (TTM) | -17.52% | -3.57% | Teladoc Health |
| Free Cash Flow (TTM) | $-164.68M | $169.63M | Teladoc Health |
| 1-Year Return | 17.59% | -0.33% | Schrodinger |
| Price-to-Sales Ratio (TTM) | 6.37 | 0.63 | Teladoc Health |
| Enterprise Value | $1.18B | $1.95B | Teladoc Health |
| EV/Revenue Ratio | 4.96 | 0.77 | Teladoc Health |
| Gross Profit Margin (TTM) | 47.77% | 69.85% | Teladoc Health |
| Revenue per Share (TTM) | $3 | $15 | Teladoc Health |
| Earnings per Share (Diluted) | $-2.48 | $-1.15 | Teladoc Health |
| Beta (Stock Volatility) | 1.74 | 1.91 | Schrodinger |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Schrodinger vs Teladoc Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Schrodinger | 3.40% | 6.68% | 6.74% | -2.51% | 9.11% | 0.93% |
| Teladoc Health | -4.88% | 10.42% | 16.11% | 8.69% | 19.65% | -5.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Schrodinger | 17.59% | -16.06% | -63.70% | -35.49% | -35.49% | -35.49% |
| Teladoc Health | -0.33% | -64.15% | -95.87% | -47.77% | -67.82% | -67.82% |
News Based Sentiment: Schrodinger vs Teladoc Health
Schrodinger
News based Sentiment: MIXED
Schrodinger experienced a blend of positive and negative developments in October. While the Q2 earnings beat and analyst upgrade were encouraging, the stock's volatility, mixed analyst ratings, and continued unprofitability create a complex investment picture. The company's future success depends heavily on its drug pipeline and software business growth.
Teladoc Health
News based Sentiment: MIXED
October was a month of conflicting signals for Teladoc, with continued financial challenges offset by a surprising stock surge and strategic initiatives. The regulatory environment remains a key risk, creating a mixed outlook for investors. The combination of positive market reaction and underlying financial concerns makes this a significant month for the company.
Performance & Financial Health Analysis: Schrodinger vs Teladoc Health
| Metric | SDGR | TDOC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.52B | $1.59B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,092,130 | 8,888,160 |
| 90 Day Avg. Volume | 1,035,247 | 5,961,557 |
| Last Close | $21.29 | $8.57 |
| 52 Week Range | $16.60 - $28.47 | $6.35 - $15.21 |
| % from 52W High | -25.22% | -43.66% |
| All-Time High | $117.00 (Feb 22, 2021) | $308.00 (Feb 15, 2021) |
| % from All-Time High | -81.80% | -97.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | -0.02% |
| Quarterly Earnings Growth | 0.16% | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | -0.76% | -0.08% |
| Operating Margin (TTM) | -0.97% | -0.07% |
| Return on Equity (TTM) | -0.44% | -0.14% |
| Debt to Equity (MRQ) | 33.38 | 72.78 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.66 | $8.05 |
| Cash per Share (MRQ) | $6.12 | $3.85 |
| Operating Cash Flow (TTM) | $27.50M | $303.43M |
| Levered Free Cash Flow (TTM) | $-6,255,750 | $209.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Schrodinger vs Teladoc Health
| Metric | SDGR | TDOC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.39 | -1.50 |
| Forward P/E | -8.34 | -10.12 |
| PEG Ratio | -2.19 | 0.02 |
| Price to Sales (TTM) | 6.37 | 0.63 |
| Price to Book (MRQ) | 4.42 | 1.12 |
| Market Capitalization | ||
| Market Capitalization | $1.52B | $1.59B |
| Enterprise Value | $1.18B | $1.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.96 | 0.77 |
| Enterprise to EBITDA | -6.33 | 103.14 |
| Risk & Other Metrics | ||
| Beta | 1.74 | 1.91 |
| Book Value per Share (MRQ) | $4.66 | $8.05 |
Financial Statements Comparison: Schrodinger vs Teladoc Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SDGR | TDOC |
|---|---|---|
| Revenue/Sales | $59.55M | $629.37M |
| Cost of Goods Sold | $28.43M | $196.83M |
| Gross Profit | $31.12M | $432.54M |
| Research & Development | $45.84M | $69.96M |
| Operating Income (EBIT) | $-50.89M | $-54.94M |
| EBITDA | $-36.21M | $50.34M |
| Pre-Tax Income | $-59.78M | $-111.27M |
| Income Tax | $28,000 | $-18.26M |
| Net Income (Profit) | $-59.81M | $-93.01M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SDGR | TDOC |
|---|---|---|
| Cash & Equivalents | $326.00M | $679.62M |
| Total Current Assets | $570.94M | $1.07B |
| Total Current Liabilities | $165.47M | $401.77M |
| Long-Term Debt | $99.41M | $1.03B |
| Total Shareholders Equity | $373.50M | $1.42B |
| Retained Earnings | $-585.35M | $-16.36B |
| Property, Plant & Equipment | $132.60M | $27.67M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SDGR | TDOC |
|---|---|---|
| Operating Cash Flow | $153.46M | $89.56M |
| Capital Expenditures | $-596,000 | N/A |
| Free Cash Flow | $143.47M | $31.63M |
| Debt Repayment | $-14,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SDGR | TDOC |
|---|---|---|
| Shares Short | 10.52M | 23.82M |
| Short Ratio | 10.53 | 5.40 |
| Short % of Float | 0.26% | 0.15% |
| Average Daily Volume (10 Day) | 1,092,130 | 8,888,160 |
| Average Daily Volume (90 Day) | 1,035,247 | 5,961,557 |
| Shares Outstanding | 72.87M | 173.41M |
| Float Shares | 57.82M | 174.74M |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 1.08% | 0.74% |
Dividend Analysis & Yield Comparison: Schrodinger vs Teladoc Health
| Metric | SDGR | TDOC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |